of epidemiologic studies have also shown significant association with periodontitis. 7 However, it is not clear whether this association is due to sharing common risk factors or whether there are underlying mechanisms linking both diseases. Some authors have hypothesized a comorbidity effect because both diseases result in systemic inflammation, 8 whereas others have postulated that hyperglycemia and altered insulin activity, so frequent in obese individuals, may be directly associated with periodontitis. 9 Other hypotheses, such as the possible effect of mobile oral microbiome on the gut 10 or changes in systemic oxidative stress, 11 have not been clearly elucidated.
Therefore, this experimental investigation aims to evaluate systemic effects of obesity and periodontitis, independently and as comorbidity, using validated experimental models.
MATERIALS AND METHODS

Animals and experimental design
This preclinical in vivo investigation was designed following guidelines for Animal Research: Reporting In Vivo Experiments (ARRIVE) 12 with a randomized block, examinermasked experimental study evaluating four groups of Wistar rats.
The experimental part of the study was carried out at the Experimental Animal Center, University Complutense of Madrid, Madrid, Spain, once the study protocol as well as animal care and welfare were approved by the Institutional Animal Care, University Complutense of Madrid, Madrid, Spain and regional authorities.
Twenty-eight 2-month-old male Wistar rats with initial body weight of 180 g were used. This investigation was conducted according to Spanish and European Union regulations (European Communities Council Directive 86/609/EEC) on experimental in vivo experimentation. 13 All procedures that implicated any pain were made under anesthesia using a mixture of ketamine (0.08 mL/100 g)/xylacine (0.04 mL/100 g) under appropriate concentrations. 14 Animals were maintained during the study under standard conditions with controlled light (12-hour light/12-hour dark schedule; lights on at 08:00 hours) and temperature (22 • C ± 2 • C), and they were weighed once a week for 11 weeks.
Experimental animals were first distributed randomly in two groups according to a differential diet used to induce obesity and, once obesity was induced, in the hypercaloric diet group. Both obese and control groups were randomly distributed into two further groups, with or without periodontal induction with periodontopathogens, resulting in four experimental groups: 1) control diet and no periodontitis (Con); 2) high-fat diet and no periodontitis (HFD); 3) control diet with induced periodontitis (Con-Perio); and 4) high-fat diet with induced periodontitis (HFD-Perio).
Obesity induction
Rats in the Con group were fed ad libitum with a standard diet * containing 3% fat, 60% carbohydrates, 16% protein, and 21% vitamins and minerals in 100 g of chow.
Rats in the HFD group were fed ad libitum with a highfat diet † containing 35.2% fat, 35.5% carbohydrates, 20.4% protein, and 8.9% vitamins and minerals in 100 g of chow.
The specific food and caloric intake were administered throughout the experiment according to group assignment, and the following nutritional parameters were recorded: 1) energy intake (kilojoules per day) = mean food consumption × dietary used energy; and 2) feed efficiency (FE, in percentage) = (mean body weight gain × 100)/energy intake.
Furthermore, abdominal circumference (AC) (immediately anterior to the forefoot), thoracic circumference (ThC) (immediately behind the foreleg), and body length (nose-to-anus length) were determined in all rats at the beginning (week 1) and end of the experiment (week 24). Body weight and length were used to determine body mass index (BMI) (square centimeters) = [body weight (grams)/length (centimeters)]/length (centimeters) and Lee index = cube root body weight (grams)/nose-to-anus length (centimeters). 15 
Periodontitis induction
When the body weight of rats in the HFD group reached values 25% higher than those in the Con group (after ≈ 60 days of treatment), each group was subdivided into two groups (n = 7), with and without periodontitis induction.
Two periodontal pathogens Porphyromonas gingivalis strain ATCC W83K1 and Fusobacterium nucleatum strain DMSZ 20482 were used to induce experimental periodontitis. These bacteria were grown in brain heart infusion broth ‡ under anaerobic conditions (80% N 2 , 10% H 2 , 10% CO 2 ) at 37 • C. When the solution reached a pre-established concentration (10 9 cells/mL, adjusted by spectrophotometry at 550 nm) it was centrifuged (10 minutes at 4,000 rpm) to separate the bacteria from the culture medium. The resulting bacteria were resuspended in sterile 2% carboxymethyl cellulose § and vortexed (200 to 300 rpm in continuous mode for 1 to 2 minutes). One milliliter of each bacterial suspension was combined and used for inducing periodontitis. 16 The suspension was administered through oral gavages on four consecutive days for 12 weeks using a sterile syringe without anesthesia (based on a pilot study; unpublished data).
Bacterial culture growth phase, suspension media, infection dose, and induction procedures were all standardized using the same preparations and infection protocols throughout the study.
Euthanasia
Rats were euthanized by decapitation under conditions of minimal stress, starting at 09:00 hours of week 26 without anesthesia.
Periodontal outcome measurements
The modified gingival index (MGI), according to Lobene et al., 17 was used to evaluate gingival inflammation using the following criteria: 1) 0 = absence of inflammation; 2) 1 = mild inflammation or with slight changes in color and texture but not in all portions of gingival margin or papilla; 3) 2 = mild inflammation in all portions of gingival margin or papilla; 4) 3 = moderate inflammation, erythema, edema, and/or hypertrophy of gingival margin or papilla; and 5) 4 = severe inflammation, erythema, edema, and/or marginal gingival hypertrophy of the unit or spontaneous bleeding, papillary congestion, or ulceration.
Probing depth (PD) was recorded using a round-ended probe tip (0.4 mm in diameter) * under magnification. PD was recorded from the gingival margin to the bottom of the sulcus/pocket and 0.5 mm was used as the measurement threshold, with mean < 0.5 mm considered healthy in rats 18 and ≥ 0.5 considered to be associated with periodontitis. 19, 20 All periodontal parameters were recorded by one masked specialist in periodontology (JG) using magnifying loupes.
Systemic outcome measurements
For the glucose tolerance test (GTT), a dose of 2 g of glucose per kilogram of rat weight was administered intraperitoneally at week 24. Blood samples collected from nicked tails were obtained at 0 (baseline), 15, 30, 60, and 120 minutes, 21 and blood glucose levels were measured using a glucometer. †
Blood samples
After euthanasia, trunk blood was collected in polystyrene EDTA tubes, ‡ and plasma was obtained by centrifugation of blood at 1,500 rpm for 15 minutes. Plasma samples were stored at −80 • C until further analysis. Interleukin (IL)-1 , IL-6, tumor necrosis factor (TNF)-, monocyte chemoattractant protein (MCP)-1, insulin, adiponectin, and leptin concentrations were measured through high-sensitivity multiplex map rat immunoassays § using a platform flow cytometry analyzer. ¶ Results were analyzed using clinical diagnostic software # and were expressed as picograms per milliliter.
Visfatin and resistin plasma concentrations were measured using a rat-specific enzyme-linked immunoassay (ELISA) kit, ‖ with an ELISA plate reader at 405 nm for measuring optical densities. Results were expressed as nanograms per milliliter.
Plasma free fatty acids (FFAs), triglycerides (TGs), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were determined by colorimetric kits * * Endotoxin levels in plasma were determined using a limulus amebocyte lysate test with 1/10 dilutions of plasma samples. † †
Liver and gingival tissue
Liver tissue (100 mg) and gingival tissue (10 mg) were homogenized using lysis beads and matrices ‡ ‡ in 1 mL of phosphate buffer with protease inhibitor and < 2% triton. Proinflammatory cytokines IL-1 , IL-6, TNF-, and MCP-1 were measured using a flow cytometry analyzer as described above.
Biomarker evaluation was done by experienced, masked biochemists (LV, PC, VJ-O, PF-M) well trained in ELISA, flow cytometry, and other biochemical assays.
Statistical analyses
Sample size was calculated considering the frequency of spontaneous periodontitis reported in rats in the Con group versus those in the HFD group 22 and incidence of induced periodontitis using the gavage periodontal pathogens method. 16 Data were expressed as mean ± SEM and 95% confidence intervals. For all evaluated parameters, normality was tested by Shapiro-Wilk test and an appropriate statistical test was § Millipore, Billerica, MA. ¶ Luminex-200 system and XY platform, Luminex, Oosterhout, The Netherlands. # Luminex. Data are expressed as mean ± (SEM). a P < 0.05 compared with the Con group. b P < 0.05 compared with the Con-Perio group. c P < 0.05 compared with the HFD group; one-way ANOVA and post-hoc Tukey multiple comparison test. At baseline, all animals were in the same group. At week 11, the Con group was fed with standard diet and the obese were fed with HFD. At week 23, there were four groups: control, obese, control induced periodontitis, and obese induced periodontitis. a P < 0.001; in week 23, differences between the HFD versus Con group. b P < 0.01; in week 23, differences between the HFD versus Con group. c P < 0.05; univariate ANOVA and independent samples t test or ANOVA; in week 23, differences between the Con-Perio and HFD-Perio versus Con group.
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selected according to this assumption. Analysis of variance (ANOVA) or independent t tests were used to determine differences among groups. All analyses were performed using statistical software. * The animal was the unit of analysis and level was set at 0.05.
RESULTS
Obesity induction
Body weight of the animals at baseline was ≈ 180 g. Irrespective of the diet used, daily food intake measured throughout the experiment was similar in both groups (16.3 ± 0.26 g in the HFD group and 18.1 ± 0.83 g in the Con group). Rats fed with the hyperlipidic and hypercaloric diet showed significant increase in body weight (P < 0.05) after week 4, compared with rats fed with the control diet. 
Periodontitis induction
Results from periodontal outcome measurements are presented in Table 2 . At baseline, all rats presented PDs associated with periodontal health (< 0.5 mm). In the HFD group, significant increase in PD occurred between baseline and week 11, PD differences between the HFD and Con group being statistically significant (P < 0.05). Similarly, the periodontitis-induced group showed significantly increased PDs throughout the experiment, and compared with the noninduced periodontitis group, differences in PD were statistically significant (P < 0.05) at week 11. The HFD-Perio group had significantly deeper PDs than the HFD group. According to MGI at the end of the experiment, statistically significant differences (P < 0.05) appeared among the four groups.
GTT
No statistically significant differences among groups (P > 0.05) were noted in fasting blood glucose levels at baseline measurements. However, at 2 hours, statistically Table 3 presents data on blood lipid levels. Plasma levels of FFA were significantly higher (P < 0.01) in the HDF-Perio group (0.68 ± 0.07 mM) than in the Con (0.36 ± 0.04 mM) and Con-Perio (0.39 ± 0.03 mM) groups. Significant rise in TGs (P = 0.009) was observed in the groups with induced periodontitis, the highest values being observed in the HFDPerio group. TC levels were significantly higher in the HFDPerio group (118.19 ± 6.49 mg/dL) than in the Con group (94.46 ± 2.61 mg/dL), although no significant differences were observed between the HFD-Perio and HFD groups (P > 0.05). HDL-C levels showed a tendency to diminish in the HFD-Perio group (63.54 ± 4.15 mg/dL) compared with the HFD group (64.74 ± 9.09 mg/dL), although these differences were not statistically significant. Figure 2 summarizes changes in plasma cytokine levels. Proinflammatory cytokines IL-1 , MCP-1, and TNFshowed statistically significantly higher levels (P < 0.05) in the induced periodontitis groups than in the non-induced periodontitis group, except plasma levels of IL-6, with similar levels among the groups. Statistically significant difference was observed between the Con-Perio and HFD-Perio groups for IL-1 (P < 0.01). Table 3 presents results for insulin and adiponectin levels. The HFD-Perio group demonstrated the highest concentrations of insulin, with statistically significant differences compared with the other groups (P < 0.01). Plasma concentrations of leptin, visfatin, and resistin also showed a tendency to increase in rats with induced periodontitis, mainly in the HFD-Perio group. By contrast, plasma adiponectin levels were reduced in the induced periodontitis groups.
Biochemical results
Plasma levels of transaminases (AST and ALT) are shown in Table 3 . At the end of the experiment, there were no statistical differences for AST and ALT levels among the groups, although there was a tendency to higher values in the induced periodontitis groups.
Similarly, plasma endotoxin levels were higher in the induced periodontitis groups, although differences between the Con-Perio and Con groups were not statistically significant (1.83 EU/ml ± 0.15 versus 1.59 ± 0.25, respectively), except for the HFD-Perio group demonstrating significantly higher levels (2.76 EU/ml ± 0.39).
Among the proinflammatory cytokines analyzed in the liver, only IL-1 demonstrated statistically significant differences between the HFD and Con groups (P < 0.05). Other studied cytokines the HFD-Perio group showed higher levels, but these differences were not statistically significant. On the other hand, all analyzed cytokines in gingival tissue presented statistically significant differences (P < 0.05) between the Con and HFD-Perio groups (Figure 3 ).
DISCUSSION
This in vivo experimental investigation shows that both obesity and periodontitis have significant systemic effects in terms of inducing systemic inflammation as well as in metabolic dysregulation. This investigation also shows the comorbidity effect on systemic parameters demonstrated by the significantly increased levels of insulin and glucose in the HFD-Perio group. This group also showed significantly increased levels of FFA and TC. In terms of systemic inflammation, proinflammatory cytokines IL-1 , MCP-1, and TNF-levels were statistically significantly higher in the induced periodontitis groups than in the non-induced periodontitis group. Furthermore, statistically significant difference was observed between the HFD-Perio and Con-Perio groups for IL-1 (P < 0.01). Similar results were obtained for plasma endotoxin levels, with the HFD-Perio group showing significantly higher levels compared with the other experimental groups.
When analyzing these results, experimental induction methods must be considered. In this experimental design, a diet-induced obesity model was selected to evaluate a pure environmental effect of diet on obesity and thus discard a possible effect of genetics. 23, 24 However, there is controversy about the relative contribution of genetics versus the environment on net increase in body weight. In humans, use of genetic screening has shown that only a relatively small number of individuals have partial or complete mutation in the leptin gene or its receptor. 4 Therefore, 
T A B L E 3 Biochemical biomarkers
Con
F I G U R E 2
Plasma concentration of cytokines analyzed by flow cytometry. Data are expressed as mean ± SEM. *P < 0.05, † P < 0.01; univariate ANOVA and independent samples t test or ANOVA and post-hoc Tukey multiple comparison test. ‡ Differences between the induced periodontitis groups and the Con group a validated experimental model using a hypercaloric diet, with well-known composition, was chosen. 25 Although there are different experimental models to induce periodontitis in rodents, mainly using ligatures, the oral gavage model was chosen combining P. gingivalis and F. nucleatum, two well-characterized periodontal pathogens that have shown agonistic characteristics and that have, in previous experiments, demonstrated induction of periodontal inflammation and periodontal destruction in rodents. 26, 27 In comparison with other induced periodontitis models in rodents, it is well established that periodontal destruction occurs more rapidly when using cotton ligatures, but the present study avoids traumatic lesion secondary to subgingival placement of ligatures because trauma itself could induce a systemic effect and the goal is to study systemic effects of both diseases without any other secondary influence. 28 The periodontitis induction model used with oral gavages of P. gingivalis and F. nucleatum resulted in significant increase of inflammatory parameters associated with periodontitis (PD and gingival inflammation). It is true that no evaluation of bone loss has been made and, therefore, the definition of periodontitis by increased PD and gingival inflammation may be weak because these parameters reflect local inflammatory changes rather than periodontal destruction. There are clear descriptions of periodontal destructive changes that occur concomitant with local inflammatory changes when this oral gavage periodontal induction model has been used in similar experimental models. 16 It is worth noting that this experimental model has been criticized especially in short time periods of exposure to bacteria. 29 However, relatively long periods of exposure have been used in the present study, which have shown clear local inflammatory response.
When analyzing the periodontal effects of obesity alone, there was a clear increase in inflammatory parameters associated with periodontitis, with significant increases in PD at week 11 in the HFD group compared with the Con group. These results are coincident with those reported by Cavagni et al., 22 who showed that the cafeteria diet was associated with increased occurrence of periodontal disease. This "periodontal effect" of the hypercaloric diet may be explained by metabolic effects of obesity, including insulin resistance and dyslipidemia, leading to hyperglycemia and type 2 DM, which are significant risk factors of periodontal inflammation and tissue destruction. 30 When obese rats (HFD group) were compared with obese rats with periodontitis (HFD-Perio group), the comorbidity effect was clearly demonstrated at the periodontal level, with significantly deeper PDs in the HFD-Perio group than in the HFD group. At the systemic level, results of the GTT showed statistically higher glycemic levels in the HFD group than in the HFD-Perio and Con groups. However, the comorbidity effect was again shown, with significantly higher glucose levels in the HFD groups (HFD and HFD Perio) than in the controls (CON and CONP Perio). This effect was probably due to systemic inflammation elicited by Gram-negative bacteria, which may contribute to increased insulin resistance and poor glycemic control. 31 Systemic inflammation associated with periodontitis was clearly demonstrated in this experimental study by the significantly elevated systemic levels of cytokine concentrations (IL-1 , TNF-, and MCP-1) in the HFD-Perio and ConPerio group compared with the HFD and Con groups. The comorbidity effect (HFD-Perio significantly higher than ConPerio) was only demonstrated for IL-1 . These results may be explained by a desensitizing effect of obesity on immune cells 32 or by changes in cytokine levels through the circadian cycles. 25 The relatively low increments of some proinflammatory cytokines (IL-6) demonstrated in the HFD-Perio group could be explained by negative regulation of some proinflammatory mediators as part of the host-immune defense against septic shock (homotolerance phenomenon). 33, 34 These results are in disagreement with a recent study from Cavagni et al., 35 who did not find any significant difference in glucose levels or biomarkers of systemic inflammation when comparing obese Wistar rats with or without periodontitis. However, Cavagni et al., 35 study used different methodologies to induce periodontitis and obesity and different evaluation times.
In the present study, the HFD-Perio and Con-Perio groups were also associated with dyslipidemia (elevated levels of TGs and TC, and low HDL-C), which is consistent with experimental and epidemiologic studies associating periodontitis with atherosclerosis and increased risk of cardiovascular diseases. 36 Mechanisms related with this effect may be also explained by systemic inflammation, mainly through elevated concentrations of IL-1 shown in the HFD-Perio and Con-Perio groups, which may have a negative effect on lipid metabolism. Another plausible mechanism may be the direct effect of lipopolysaccharide from P. gingivalis, which has shown a direct effect on lipid metabolism in obesity. 37 Furthermore, FFAs appear to be the major mediators of excessive fat accumulation in the liver. In patients with non-alcoholic steatohepatitis, elevated serum FFA levels are considered a potential endogenous risk factor. 38, 39 In this study, FFA and other liver damage markers such as AST and ALT were elevated in the HFD-Perio group, which could indicate a potential added effect of periodontitis to the characteristic liver dysregulation caused by obesity. 40 Hepatic damage caused by comorbidity was also demonstrated by the significantly higher concentration of IL-in the liver in the HFD-Perio group. Whether this deleterious effect of periodontitis in the liver is caused by direct P. gingivalis infection or indirectly through systemic inflammation remains to be elucidated. 41 The comorbidity effect of periodontitis was also shown through the imbalance between levels of proinflammatory and anti-inflammatory adipokines shown in the HDF-Perio group. Plasma levels of resistin, visfatin, and leptin were higher in the HFD-Perio group than in the other groups. In contrast, plasma concentration of anti-inflammatory adiponectin was lower in the HDF-Perio group than in the other groups. These data may indicate that obesity with periodontitis significantly increases systemic inflammation and, therefore, may decrease immune response to infection.
CONCLUSION
This experimental investigation shows the comorbidity effect of periodontitis and obesity, at periodontal and systemic levels, by demonstrating increased periodontal severity and increased systemic inflammation and metabolic dysregulation affecting glucose metabolism, dyslipidemia, and hepatic damage.
